A Systematic Framework for Pediatric Acute Decompensated Heart Failure

Pediatric acute decompensated heart failure (ADHF) has historically lacked comprehensive, standardized guidance for assessment, management, and discharge planning. A new American Heart Association (AHA) scientific statement in Circulation narrows this gap by proposing a more systematic approach for children with ADHF. The statement synthesizes registry data, adult trial evidence, and expert consensus into a practical framework across three care settings: the emergency department (ED), the intensive care unit (ICU), and the inpatient floor.

Emergency Department: Identify the Hemodynamic Profile

The first task is distinguishing a low-output state from congestion, since ADHF can mimic sepsis and inappropriate fluid resuscitation in a hypotensive child may worsen decompensation. Diagnostic workup includes B-natriuretic peptide (BNP), chest radiograph, electrocardiogram, and echocardiogram. Treatment centers on early decongestion with loop diuretics and initiation of noninvasive respiratory support and/or vasoactive agents. The statement flags specific ICU-admission triggers clinicians should watch for: respiratory distress, unstable arrhythmias, complex congenital heart disease, need for vasoactives/inotropes, or need for narcotics for comfort.

Intensive Care: Monitor, Support, and Stage the Cardiogenic Shock

Once admitted, the diagnostic focus can shift to hemodynamic monitoring—central venous pressure, near-infrared spectroscopy, mixed venous oxygen saturation, and blood pressure—along with staging cardiogenic shock (CS) using a modified Society for Cardiovascular Angiography and Interventions (SCAI), and assessing the need for mechanical circulatory support (MCS).

A pediatric study cited by the statement found that about 1 in 4 children presenting with ADHF experienced CS. The study found a graded increase in mortality with each stage, from 7% in stage A to 36% in stage E. However, the authors caution that several assessments routinely used to identify shock in adults were not consistently obtained in this pediatric cohort, which limits confidence in the true prevalence of CS across the broader pediatric ADHF population. Hence, the statement identifies the development of a dedicated pediatric grading system for CS as a key priority.

Treatment involves intermittent or continuous loop diuretic infusion, endotracheal intubation with extracorporeal membrane oxygenation (ECMO) on standby if warranted, and selection among peripheral ECMO, central ECMO, or a percutaneous microaxial pump when MCS is needed. This is also the point at which nutrition/rehabilitation should begin and vasoactives should be weaned as oral HF therapies are started.

Inpatient Floor: Consolidate and Plan for Discharge

As the child stabilizes, diagnosis becomes ongoing monitoring—serial BNP, echocardiogram, and clinical assessment—while treatment may shift to advancing oral heart failure therapies to therapeutic doses, continuing nutrition and rehabilitation, and discharge planning that includes an early return appointment. These steps are particularly important given that 30-day heart failure-related readmission after a first pediatric ADHF exacerbation is estimated at 22%.

Despite this emphasis on advancing oral therapies before discharge, guideline-directed medical therapy remains markedly underused in children. Only about 65% of children with ADHF receive an ACE inhibitor or ARB at discharge, and fewer than 20% receive the full standard combination (ACEi/ARB + β-blocker + aldosterone antagonist)—a rate that has not improved in a decade and represents a concrete, actionable quality-improvement target.

Conclusions

A central message of the statement is the need for systematic management across the hospital course, including earlier recognition and escalation when a child's condition deteriorates, coupled with continuous reassessment of whether the patient is progressing toward recovery or stalling. Pediatric ADHF should be managed as an evolving hemodynamic state, with treatment adjusted as the child moves toward recovery or deterioration. Extending that approach from initial evaluation through stabilization and discharge may offer clinicians a more consistent framework for managing these high-risk patients.

Reference:
Cabrera AG, Price JF, Hong BJ, et al. Evaluation and management of the child with acute decompensated heart failure: a scientific statement from the American Heart Association. Circulation. 2026;153:e1323-e1335. doi:10.1161/CIR.0000000000001428